Our strategies / Our investment strategies
Our investment strategies
Forbion is a leading venture capital firm investing in innovations that advance both, human and planetary health.
- In human health, we support transformative biopharma companies from pre-seed and early-stage formation through development and commercialization, leveraging dedicated funds through joint ventures with BGV (which runs First), and our Forbion Ventures and Growth funds.
- On the planetary health side, Forbion supports companies through its BioEconomy fund, focusing on sustainable solutions from early-stage to growth.
Together, these strategies reflect our mission of impacting the future by supporting pioneering companies that improve lives and protect the planet.
Human Health
Formation
Forbion runs a joint venture with BioGeneration Ventures (BGV). BGV together with its FIRST Fund, is the early-stage strategy of our platform.
Ventures
Forbion Ventures enables and builds new companies. Most of these concentrate on Series A and Series B rounds.
Growth
Forbion Growth enables company expansion and focuses on private growth capital, European cross-overs and under-valued assets.
Pre Seed
Early-stage
Development
Commercialisation
Pre-Seed
Early-stage
Development
Commercialisation
Company Formation
Pre-creation
Pre-Seed
Company Formation
Company creation
Build, Seed
Series A rounds
Ventures Fund
Company building
Build, Enable Series
Series A, B rounds
Growth Opportunities Fund
Company expansion
Private growth capital, crossovers,
PIPE / VPE / Block trades
Planetary Health
BioEconomy
Forbion BioEconomy focuses on innovative companies that leverage biotechnology to clean and feed the planet across four sectors.
BioEconomy Fund
Environmental solutions
Series A, B stages
Early-stage
Development